Persistent inflammation-immunosuppression-catabolism syndrome in patients with systemic lupus erythematosus

被引:3
|
作者
Li, Zhe [1 ]
Hu, Weixin [1 ]
Wang, Yang [1 ]
Xu, Shutian [1 ]
Zhou, Yuchao [1 ]
Li, Shijun [1 ]
机构
[1] Nanjing Univ, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Sch Med, 305 East Zhongshan Rd, Nanjing 210016, Jiangsu, Peoples R China
关键词
Systemic lupus erythematosus; Persistent inflammation-immunosuppression-catabolism syndrome; Chronic critical illness; GLUCOCORTICOID THERAPY; SEPSIS; LYMPHOPENIA; GUIDELINES; MANAGEMENT; DISEASES;
D O I
10.1007/s11255-023-03479-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveTo evaluate the clinical characteristics and prognosis of systemic lupus erythematosus (SLE) with persistent inflammation-immunosuppression-catabolism syndrome (PICS).MethodsWe retrospectively analyzed patients with SLE who were admitted to the renal intensive care unit (ICU) for over 14 days at Jinling Hospital from July 2010 to July 2018. According to the diagnostic criteria of PICS, we divided the SLE patients into a PICS group and a non-PICS group. We performed a multivariate Cox regression analysis on the risk factors for death in these two groups by comparing the clinical features and prognosis.ResultsA total of 96 SLE patients met the inclusion and exclusion criteria of this study, including 61 patients in the PICS group and 35 patients in the non-PICS group. The PICS group patients required a longer length of stay in ICU with higher inflammatory indicators (such as C-reactive protein, procalcitonin and interleukin-6) and lower immune levels (such as total, CD3 + , CD4 + , CD8 + and CD20 + lymphocytes) compared to the non-PICS group patients (P < 0.01). Hemoglobin, platelets, serum creatinine, serum blood urea nitrogen and SLE Disease Activity Index (SLE-DAI) score in the PICS group were lower than those in the non-PICS group (P < 0.05), suggesting severe hematological injury in the PICS group and relatively severe renal damage in the non-PICS group. The rates of PICS combined with sepsis, acute respiratory distress syndrome, mechanical ventilation, gram-positive bacteria, gram-negative bacteria, fungi and double infections were higher than those in the non-PICS group (P < 0.05). The 3-year survival rate was 50.82% in the PICS group and 85.71% in the non-PICS group. The 3-year renal survival rate was 32.79% in the PICS group and 51.43% in the non-PICS group. Multivariate Cox regression found that the total lymphocyte count during ICU admission was an independent risk factor for death in SLE patients with PICS.ConclusionPatients with SLE complicated with PICS had longer ICU stays, a lower level of SLE activity, a higher risk of secondary infection and a significantly lower survival rate than non-PICS patients.
引用
收藏
页码:1757 / 1765
页数:9
相关论文
共 50 条
  • [1] Persistent inflammation–immunosuppression–catabolism syndrome in patients with systemic lupus erythematosus
    Zhe Li
    Weixin Hu
    Yang Wang
    Shutian Xu
    Yuchao Zhou
    Shijun Li
    International Urology and Nephrology, 2023, 55 : 1757 - 1765
  • [2] Inflammatory Response and Anti-Inflammatory Treatment in Persistent Inflammation-Immunosuppression-Catabolism Syndrome (PICS)
    Xiong, Dacheng
    Geng, Huixian
    Lv, Xuechun
    Wang, Shuqi
    Jia, Lijing
    JOURNAL OF INFLAMMATION RESEARCH, 2025, 18 : 2267 - 2281
  • [3] Persistent Inflammation, Immunosuppression and Catabolism Syndrome
    Sarikaya, Zeynep Tugce
    Akmci, Ibrahim Ozkan
    TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI, 2020, 18 (01): : 1 - 5
  • [4] Persistent Inflammation, Immunosuppression and Catabolism Syndrome
    Mira, Juan C.
    Brakenridge, Scott C.
    Moldawer, Lyle L.
    Moore, Frederick A.
    CRITICAL CARE CLINICS, 2017, 33 (02) : 245 - +
  • [5] Predictive value of early measurement of cytokine levels for persistent inflammation-immunosuppression-catabolism syndrome in ICU patients: A retrospective study
    Hu, Yongxia
    Wang, Yun
    Guo, Shan
    Zhang, Weimin
    EUROPEAN JOURNAL OF INFLAMMATION, 2024, 22
  • [6] HDL and persistent inflammation immunosuppression and catabolism syndrome
    Barker, Grant
    Weiner, Justin R.
    Guirgis, Faheem W.
    Reddy, Srinivasa
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (05) : 315 - 322
  • [7] Persistent, Immunosuppression, Inflammation, Catabolism Syndrome and Diaphragmatic Dysfunction
    Martin D. Rosenthal
    Cameron M. Rosenthal
    Frederick A. Moore
    Robert G. Martindale
    Current Pulmonology Reports, 2017, 6 (1) : 54 - 57
  • [8] Nutrition Support for Persistent Inflammation, Immunosuppression, and Catabolism Syndrome
    Moore, Frederick A.
    Phillips, Stuart M.
    McClain, Craig J.
    Patel, Jayshil J.
    Martindale, Robert G.
    NUTRITION IN CLINICAL PRACTICE, 2017, 32 : 121S - 127S
  • [9] Lymphocyte Immunosuppression and Dysfunction Contributing to Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS)
    Bergmann, Christian B.
    Beckmann, Nadine
    Salyer, Christen E.
    Crisologo, Peter A.
    Nomellini, Vanessa
    Caldwell, Charles C.
    SHOCK, 2021, 55 (06): : 723 - 741
  • [10] The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later
    Efron, Philip A.
    Brakenridge, Scott C.
    Mohr, Alicia M.
    Barrios, Evan L.
    Polcz, Valerie E.
    Anton, Stephen
    Ozrazgat-Baslanti, Tezcan
    Bihorac, Azra
    Guirgis, Faheem
    Loftus, Tyler J.
    Rosenthal, Martin
    Leeuwenburgh, Christian
    Mankowski, Robert
    Moldawer, Lyle L.
    Moore, Frederick A.
    JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2023, 95 (05): : 790 - 799